SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
136 hedge funds and large institutions have $268M invested in SANGAMO THERAPEUTICS INC in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 42 reducing their positions, and 21 closing their positions.
363% more call options, than puts
Call options by funds: $5.67M | Put options by funds: $1.23M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 42
5% less funds holding
Funds holding: 143 → 136 (-7)
8% less capital invested
Capital invested by funds: $289M → $268M (-$21.8M)
33% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$8.94M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.14M |
| 3 |
AC
Ascend Capital
Orinda,
California
|
+$2.65M |
| 4 |
Millennium Management
New York
|
+$2.35M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$9.07M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$6.67M |
| 3 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$3.3M |
| 4 |
Renaissance Technologies
New York
|
-$2.48M |
| 5 |
SCM
Sio Capital Management
New York
|
-$2.39M |
SGMO Hedge Fund Activity: Q2 2016 in Review
136 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2016, worth a combined $268M — down 7.5% from $289M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of SGMO and 14 opened new positions — a net loss of 7 holders — while 42 trimmed existing stakes and 40 added.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $8.94M. The largest seller was EverPoint Asset Management, exiting entirely with an estimated $9.07M sold.
- 136 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2016, down from 143 in Q1 2016.
- Funds reported $268M of SANGAMO THERAPEUTICS INC stock for Q2 2016, down 7.5% quarter-over-quarter.
- 14 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2016 and 21 closed out, a net change of -7 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q2 2016 was Cormorant Asset Management, an estimated $8.94M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q2 2016 was EverPoint Asset Management, an estimated $9.07M sold.
Based on aggregated 13F filings for Q2 2016.